Abstract
Workflow solutions driven by data pipelining are increasingly becoming popular for accessing, aggregating and analyzing disparate data to make informed and intelligent decisions. Uses of workflow technologies which facilitate business intelligence (BI) improve productivity, decision making and research efficiency. In order to provide BI in a scientific or clinical based organization, it is imperative that the application or workflow technology must be compatible with multiple data types and formats, be able to analyze the data and make it available throughout the organization. We term this as Scientific Business Intelligence (SBI) and discuss how modeling, simulations and informatics software, integrated with open and standards-based scientific operating platform (SOP), can deliver scientifically-relevant BI solutions. We illustrate SBI with several examples encompassing all levels of users within an organization.
Keywords: Scientific business intelligence, data pipelining, workflows, web deployment, data integration, dashboard, Pipeline Pilot™
Current Computer-Aided Drug Design
Title: Changing Paradigms in Drug Discovery: Scientific Business Intelligence™ and Workflow Solutions
Volume: 4 Issue: 1
Author(s): Shikha Varma-O'Brien, Frank K. Brown, Andrew LeBeau and Robert D. Brown
Affiliation:
Keywords: Scientific business intelligence, data pipelining, workflows, web deployment, data integration, dashboard, Pipeline Pilot™
Abstract: Workflow solutions driven by data pipelining are increasingly becoming popular for accessing, aggregating and analyzing disparate data to make informed and intelligent decisions. Uses of workflow technologies which facilitate business intelligence (BI) improve productivity, decision making and research efficiency. In order to provide BI in a scientific or clinical based organization, it is imperative that the application or workflow technology must be compatible with multiple data types and formats, be able to analyze the data and make it available throughout the organization. We term this as Scientific Business Intelligence (SBI) and discuss how modeling, simulations and informatics software, integrated with open and standards-based scientific operating platform (SOP), can deliver scientifically-relevant BI solutions. We illustrate SBI with several examples encompassing all levels of users within an organization.
Export Options
About this article
Cite this article as:
Varma-O'Brien Shikha, Brown K. Frank, LeBeau Andrew and Brown D. Robert, Changing Paradigms in Drug Discovery: Scientific Business Intelligence™ and Workflow Solutions, Current Computer-Aided Drug Design 2008; 4 (1) . https://dx.doi.org/10.2174/157340908783769274
DOI https://dx.doi.org/10.2174/157340908783769274 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
High Blood Pressure and the Risk of Stroke
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Bacterial Cellulose-Based Metallic Green Nanocomposites for Biomedical and Pharmaceutical Applications
Current Pharmaceutical Design Early Functional and Structural Microvascular Changes in Hypertension Related to Aging
Current Hypertension Reviews The Use of Thiazides in Chronic Kidney Disease
Current Hypertension Reviews Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease
Current Vascular Pharmacology Endogenous Factors in the Recovery of Reproductive Function After Testicular Injury and Cancer
Current Molecular Medicine Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
Current Pharmaceutical Design Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence
Current Pharmaceutical Design Protein-Protein Interactions at the Adrenergic Receptors
Current Drug Targets PET Imaging and Coronary Circulatory Function: Non-Invasive Mechanistic Insights and Cardiovascular Prognosis
Current Cardiology Reviews Anti-Shock Garments for Obstetric Hemorrhage
Current Women`s Health Reviews The Role of Gut Microbiota in Drug Response
Current Pharmaceutical Design Micro-/nano-electroporation for active gene delivery
Current Pharmaceutical Design Simulating the Interactions of Toxins with K+ Channels
Current Pharmaceutical Design Efficient Expression and Purification of Recombinant Therapeutic Protein Candidates, Human Midkine and Pleiotrophin
Current Pharmaceutical Biotechnology Studies on the Biotransformations and Biodistributions of Metal-Containing Drugs Using X-Ray Absorption Spectroscopy
Current Topics in Medicinal Chemistry Polymorphisms at the LDLR Locus may be Associated with Ischemic Cerebrovascular Disease Independent of Lipid Profile
Current Neurovascular Research Antihypertensive Therapy in Children: Differences in Medical Approach Between the United States and Europe
Current Medicinal Chemistry Iontophoretic Mediated Intraarticular Delivery of Deformable Liposomes of Diclofenac Sodium
Current Drug Delivery Cinnamic Acid Derivatives in Tuberculosis, Malaria and Cardiovascular Diseases - A Review
Current Organic Chemistry